RPS6KA3 anticorps (N-Term)
Aperçu rapide pour RPS6KA3 anticorps (N-Term) (ABIN2354589)
Antigène
Voir toutes RPS6KA3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- RSK2, NT (Ribosomal S6 Kinase 2, RSK2, RSK-2, p90-RSK2, pp90RSK2, 90kD Ribosomal Protein S6 Kinase 3, p90-RSK 3, p90RSK3, Insulin-stimulated Protein Kinase 1, ISPK1, ISPK-1, MAP Kinase-activated Protein Kinase 1b, MAPK-activated Protein Kinase 1b, MAPKAP Kinase 1b, MAPKAPK1B, MAPKAPK-1b, Ribosomal Protein S6 Kinase alpha-3, RPS6KA3, S6K-alpha3, S6K-alpha-3)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human RSK3 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
-
Autre désignation
- RSK2
-
NCBI Accession
- NP_004577
-
UniProt
- P51812
-
Pathways
- Signalisation MAPK, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades
Antigène
-